Please login to the form below
ferumoxytol
This page shows the latest ferumoxytol news and features for those working in and with pharma, biotech and healthcare.
Amag buys into maternal health business
Adding Makena into its portfolio will give Amag an opportunity in future to increase sales of its own flagship product Feraheme (ferumoxytol), used to treat iron-deficiency anaemia in patients with
Latest news
-
Death leads to recall of batch of Takeda's Rienso in Switzerland
Marketing partner Amag also reports three other hypersensitivity reactions. Takeda has recalled a batch of its anaemia medicine Rienso (ferumoxytol) in Switzerland following four reports of hypersensitivity reactions, including one death.
-
SMC approves Eliquis, restricts use of Rienso
Meanwhile the SMC's latest round of decisions also saw it back the restricted use of Takeda's treatment for iron deficiency anaemia in chronic kidney disease (CKD) Rienso (ferumoxytol).
-
Orphan drug focus
318. AMAG Pharmaceuticals/ Takeda. feraheme (ferumoxytol) - for iron deficiency anaemia.
-
Takeda to cut 10 per cent of jobs
and Feraheme (ferumoxytol) for anaemia associated with chronic renal failure.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Interview: Trevor Smith, Takeda
iron deficiency anaemia treatment Rienso (ferumoxytol) in June.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Spectrum appoints chief medical officer
2013. The appointment is a return to oncology for Dr Allen following a six-year spell as chief medical officer at AMAG Pharmaceuticals – the developer of Feraheme (ferumoxytol) for the treatment
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Lilly’s Verzenio scores a win in early-stage breast cancer
- New study identifies drugs that are safe to use in COVID-19 treatment
- Researchers call on Pfizer to delay COVID-19 vaccine application
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Phase 1/2a results for J&J’s COVID-19 vaccine show early promise
- J&J advances COVID-19 vaccine into phase 3 testing
- Covid-19 redefines rules of customer engagement
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Aurora extends exclusive collaboration with Patient Intelligence Panel (PIP Health)
- Moderna’s COVID-19 vaccine generates strong immune response in older adults
- Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms
- What makes a great launch leader and launch team?
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Covid-19 redefines rules of customer engagement
- Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
- The concordance conundrum: understanding the complexities of behaviour change
- Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
Quick links
Infographics
